In addition, several PCAT19-containing prognostic models, such as a TIME-related signature in stomach adenocarcinoma (Zhu et al., 2022), necroptosis-related lncRNA signatures in bladder cancer (Jin et al., 2023), and necroptosis-related lncRNA signatures in uterine corpora endometrial cancer (Lin Z. et al., 2023), have been developed and demonstrated significant prognostic value in these cancers. Here, PCAT19 is linked to cancer.